Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZK 283197 vs estradiol vs placebo for vasomotor symptoms in postmenopausal women
2007-001791-36Phase 2Completed
- Sponsor
- Bayer
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ZK-283197 in vasomotor symptoms (4 arms), sponsored by Bayer. Primary endpoint: Change in weekly frequency of moderate to severe hot flushes at week 8. Started Jul 2007; status: completed.
02
Drugs
ZK-283197
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on 2007-001791-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001791-36.